Skip to content
中文产业新闻精选评分73Chinese source

强生 nipocalimab 获 FDA 批准用于温抗体型自身免疫性溶血性贫血

65亿美元收购!强生重磅单抗获批新适应症

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.